A Bayesian meta-analysis finds patients regain half their treatment-associated weight loss within about 7.5 months of stopping semaglutide or tirzepatide.
Feature|Articles|March 5, 2025
Lancet Commission Redefines Clinical Obesity, Moving Beyond BMI
Author(s)Ashley Gallagher, MA
“The Commission reinforces that obesity is a disease and not due to lack of motivation, willpower, discipline, or laziness,” Robert F. Kushner said.
Advertisement
Advertisement
In January 2025, The Lancet Diabetes & Endocrinology published its Commission on the definition of clinical obesity as well as diagnostic criteria. With the new definitions, the Commission has identified preclinical obesity as a risk factor and clinical obesity as a stand-alone illness, according to the authors.
Related to this article
The combination outperformed ixekizumab alone on skin, joint, and weight outcomes through 52 weeks.
Data shows that those who stayed on tirzepatide had monthly health care costs well below those of untreated adults.
Researchers assess the neurological outcomes of over 200,000 children exposed to COVID-19 before birth.
Results show consistent improvements in wakefulness, cataplexy, and quality of life with oveporexton for patients with narcolepsy.
Researchers assess the differences in out-of-pocket spending on brand name compared with generic medication.
Practical takeaways to improve real‑world clinic outcomes for PAINWeek 2026.
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
Advertisement
Advertisement